Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss HALO - Halozyme Therapeutics, Inc.
-9.28 M
LAST VALUE
-286.84%
2 YEAR CAGR
-101.83%
5 YEAR CAGR
-87.78%
10 YEAR CAGR